Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

droxicainide

Known as: 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-N-(2-hydroxyethyl)-, monohydrochloride, (+-)-, N-(2-hydroxyethyl)pipecolinyl-2,6-dimethylanilide 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Anilides

Narrower (1)

S-1249

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
The Acute Antiarrhythmic Effects of Droxicainide and Lidocaine in Unanesthetized Dogs
Two groups of unanesthetized dogs, each consisting of six animals with ventricular tachycardia caused by two-stage ligation of… Expand
1984
1984
Comparison of electrophysiological and mechanical effects of droxicainide and lidocaine on heart muscle isolated from rats.
A new antiarrhythmic drug, droxicainide, was compared with lidocaine in order to evaluate droxicainide's effect on heart muscle… Expand
1983
1983
Effects of lidocaine and droxicainide on myocardial necrosis: a comparative study.
Lidocaine has been shown to protect ischemic myocardium, but the degree of its effectiveness is not yet well established… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
1983
1983
Pharmacological studies on droxicainide, a new antiarrhythmic agent.
The antiarrhythmic, local anesthetic and acute local and systemic toxic effects of DL-N-(2-hydroxyethyl)-pipecolinyl-2,6… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE